Hybrid Versus Fully In-person Physiotherapy for Non-traumatic Shoulder Pain in Routine Care.
2 other identifiers
observational
129
1 country
1
Brief Summary
Prospective consecutive observational cohort study in routine care comparing hybrid versus fully in-person supervised physiotherapy for non-traumatic shoulder pain/dysfunction delivered under the standardized REHABI program. The primary outcome is time to clinical discharge (days from first visit to discharge). Secondary outcomes include change in pain (VAS/composite VAS) and change in total clinical deficit score from baseline to discharge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 11, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 11, 2025
CompletedFirst Submitted
Initial submission to the registry
January 15, 2026
CompletedFirst Posted
Study publicly available on registry
January 29, 2026
CompletedJanuary 29, 2026
January 1, 2026
8 months
January 15, 2026
January 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time to clinical discharge
Days from first visit (baseline, V1) to clinical discharge.
From baseline (V1) until discharge (end of rehabilitation episode, approximately 1 to 6 months after baseline, depending on clinical evolution)
Secondary Outcomes (2)
Change in total clinical deficit score
baseline and discharge (approximately 1 to 6 months after baseline, depending on clinical evolution)
Change in pain (VAS / composite VAS)
baseline and discharge (approximately 1 to 6 months after baseline, depending on clinical evolution)
Study Arms (2)
Group 1: Hybrid rehabilitation
One supervised in-person session plus two remote (non-face-to-face) sessions per week, delivered in 3-week cycles.
Group 2: In-person rehabilitation
Description:three supervised in-person sessions per week, delivered in 3-week cycles according to the REHABI protocol.
Eligibility Criteria
Adult patients with musculoskeletal shoulder pain treated in a private sports physiotherapy clinic in Pamplona, Spain, who are referred or self-referred for conservative management, consecutively enrolled in the REHABI digital rehabilitation program, and who have access to and basic skills to use a smartphone.
You may qualify if:
- Age 18-71 years
- Non-traumatic shoulder pain/dysfunction
- Access to a smartphone to view exercises
- Completion of a full rehabilitation episode within the study period
You may not qualify if:
- Acute fractures or dislocations
- Arthritis/osteoarthritis
- Osteosarcoma or osteomyelitis
- Recent shoulder surgery
- Incomplete rehabilitation episode or missing baseline/discharge data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
TDN Clínica Traumatología y Rehabilitación SLP
Noaín, Navarre, 31110, Spain
Related Publications (1)
Setuain I, Gonzalez-Izal M, Paularena A, Luque JL, Andersen LL, Izquierdo M. A protocol for a new methodological model for work-related shoulder complex injuries: From diagnosis to rehabilitation. BMC Musculoskelet Disord. 2017 Feb 7;18(1):70. doi: 10.1186/s12891-017-1435-2.
PMID: 28173784RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
José A Sanz, PHD
Universidad Pública de Navarra
- STUDY DIRECTOR
Igor Setuain, PHD
TDN Clinica
- STUDY DIRECTOR
Iban Latasa, PHD
IED Electronics
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 200 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 15, 2026
First Posted
January 29, 2026
Study Start
March 17, 2025
Primary Completion
November 11, 2025
Study Completion
November 11, 2025
Last Updated
January 29, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
At present, there is no plan to share individual participant data (IPD). This is a single-center study with a relatively small sample and detailed clinical assessments, which may increase the risk of re-identification, and the original informed consent did not explicitly cover broad IPD sharing. De-identified summary results will be available in the published manuscript, and additional aggregated information may be considered upon reasonable request.